Want to join the conversation?
$BAX's sales in the biopharma solutions and other category, which is its partnering business, totaled $106MM, declining 19% on a reported basis or 12% on a constant currency basis. This decline is driven by a large customers choosing to self manufacture products that were previously contract manufactured by $BAX.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?